These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34791833)

  • 1. SARS Cov-2 vaccination induces de novo donor-specific HLA antibodies in a renal transplant patient on waiting list: A case report.
    Abu-Khader A; Wang W; Berka M; Galaszkiewicz I; Khan F; Berka N
    HLA; 2022 Jan; 99(1):25-30. PubMed ID: 34791833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful ABO-incompatible living donor kidney transplantation in a recipient who developed flow cytometry crossmatch-positive donor-specific class I HLA antibodies following COVID-19 vaccination.
    Kim JK; Bae H; Ko GY; Lee J; Jung J; Jekarl DW; Choi AR; Lee S; Chung BH; Yang CW; Park SC; Oh EJ
    HLA; 2022 Jul; 100(1):52-58. PubMed ID: 35484951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of de novo HLA antibodies after COVID-19 vaccination: A cohort study of patients awaiting kidney transplantation.
    Abu-Khader A; Hu Q; Kamar F; Galaszkiewicz I; Wang W; Khan F; Berka N
    Transpl Infect Dis; 2023 Dec; 25(6):e14105. PubMed ID: 37650468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of de novo donor-specific antibody on early renal allograft function recovery.
    Zheng J; Xue W; Jing X; Hou J; Tian X; Tian P; Ding X; Pan X; Yan H; Feng X; Xiang H; Li Y; Ding C
    Ren Fail; 2015 Apr; 37(3):462-8. PubMed ID: 25697229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.
    Roll GR; Lunow-Luke T; Braun HJ; Buenaventura O; Mallari M; Stock PG; Rajalingam R
    Hum Immunol; 2021 Aug; 82(8):568-573. PubMed ID: 33910707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients.
    Nishida H; Takai S; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Tsuchiya N
    Clin Transplant; 2023 May; 37(5):e14952. PubMed ID: 36846878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination.
    Xu Q; Sood P; Helmick D; Lomago JS; Tevar AD; Zeevi A
    Am J Transplant; 2021 Nov; 21(11):3785-3789. PubMed ID: 34241963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
    Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
    Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients.
    Kueht M; Kirk K; Scott Lea A; Stevenson HL; Fair J; Kathleen Gamilla-Crudo A; Hussain S; Mujtaba M
    Hum Immunol; 2022; 83(8-9):607-612. PubMed ID: 35871882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients.
    Cordero E; Bulnes-Ramos A; Aguilar-Guisado M; González Escribano F; Olivas I; Torre-Cisneros J; Gavaldá J; Aydillo T; Moreno A; Montejo M; Fariñas MC; Carratalá J; Muñoz P; Blanes M; Fortún J; Suárez-Benjumea A; López-Medrano F; Roca C; Lara R; Pérez-Romero P
    Front Immunol; 2020; 11():1917. PubMed ID: 33123119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
    Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
    Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
    Everly MJ; Rebellato LM; Haisch CE; Ozawa M; Parker K; Briley KP; Catrou PG; Bolin P; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
    Transplantation; 2013 Feb; 95(3):410-7. PubMed ID: 23380861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications.
    Russo G; Lai Q; Poli L; Perrone MP; Gaeta A; Rossi M; Mastroianni CM; Garofalo M; Pretagostini R
    Clin Transplant; 2022 Jan; 36(1):e14495. PubMed ID: 34569101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.